Market Cap 35.70M
Revenue (ttm) 0.00
Net Income (ttm) -20.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 33,200
Avg Vol 89,746
Day's Range N/A - N/A
Shares Out 10.79M
Stochastic %K 0%
Beta 1.63
Analysts Strong Buy
Price Target $26.00

Latest News on LTRN

Lantern Pharma Inc. (LTRN) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 8:35 PM EDT - 6 days ago

Lantern Pharma Inc. (LTRN) Q4 2024 Earnings Call Transcript


Lantern Pharma Inc. (LTRN) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 7:23 PM EST - 5 months ago

Lantern Pharma Inc. (LTRN) Q3 2024 Earnings Call Transcript


Lantern Pharma Inc. (LTRN) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 4:01 AM EDT - 8 months ago

Lantern Pharma Inc. (LTRN) Q2 2024 Earnings Call Transcript


Lantern Pharma Inc. (LTRN) Q4 2023 Earnings Call Transcript

Mar 18, 2024, 11:14 PM EDT - 1 year ago

Lantern Pharma Inc. (LTRN) Q4 2023 Earnings Call Transcript


Lantern Pharma Inc. (LTRN) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 5:28 AM EST - 1 year ago

Lantern Pharma Inc. (LTRN) Q3 2023 Earnings Call Transcript


Lantern Pharma Inc. (LTRN) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 8:25 PM EDT - 1 year ago

Lantern Pharma Inc. (LTRN) Q2 2023 Earnings Call Transcript